Literature DB >> 2276855

Serum lipids after gastric bypass surgery for morbid obesity.

R E Brolin1, H A Kenler, A C Wilson, P T Kuo, R P Cody.   

Abstract

Thirty-eight of 151 consecutive patients (25 percent) undergoing bypass surgery for morbid obesity had increased serum levels of total cholesterol (TC), triglycerides (TG) or both preoperatively. Ten patients had isolated TC elevation, six had isolated TG elevation and 22 had both TC and TG elevation. High density lipoprotein-cholesterol (HDL-C) levels were subnormal in 28 of the 38 patients (74 percent). Fasting lipid profiles were determined in the 38 hyperlipidemic patients at 6-month intervals postoperatively. Mean follow-up period was 29 months. By 6 months postop, patients had a greater than or equal to 20 percent mean reduction in TC and greater than or equal to 50 percent mean reduction in TG which were significant in comparison with preop levels and correlated with weight loss (P less than or equal to 0.05). Mean HDL-C levels had increased significantly vs. preop levels by 12 months postop (P less than 0.05). Lipid profiles became normal in 32 of the 38 patients (84 percent). Improvements in lipid profile were sustained in all patients with satisfactory weight loss but regressed after 12 months in patients who did not lose greater than or equal to 50 percent of their excess weight. These results suggest that abnormal serum lipid profiles can be permanently improved with sustained weight loss after gastric restriction surgery for morbid obesity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276855

Source DB:  PubMed          Journal:  Int J Obes


  7 in total

1.  One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding.

Authors:  Gavitt A Woodard; Joseph Peraza; Stephanie Bravo; Loren Toplosky; Tina Hernandez-Boussard; John M Morton
Journal:  Obes Surg       Date:  2010-02-26       Impact factor: 4.129

2.  Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity.

Authors:  R E Brolin; L J Bradley; A C Wilson; R P Cody
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

3.  Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.

Authors:  E Pardina; M D López-Tejero; R Llamas; R Catalán; R Galard; H Allende; V Vargas; A Lecube; J M Fort; J A Baena-Fustegueras; J Peinado-Onsurbe
Journal:  Obes Surg       Date:  2009-01-27       Impact factor: 4.129

4.  Surgical caloric restriction ameliorates mitochondrial electron transport dysfunction in obese females.

Authors:  Jing Li; Ritchie J Feuers; Varsha G Desai; Sherry M Lewis; Peter H Duffy; Martha A Mayhugh; George Cowan; Cynthia K Buffington
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

Review 5.  A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.

Authors:  Kirstin A Carswell; Ajay P Belgaumkar; Stephanie A Amiel; Ameet G Patel
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

6.  Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery.

Authors:  Alberto Melchor-López; Juan Antonio Suárez-Cuenca; Diana Zaineff Banderas-Lares; Gustavo De la Peña-Sosa; Moisés Salamanca-García; Eduardo Vera-Gómez; Alejandro Hernández-Patricio; Juan Ariel Gutiérrez-Buendía; Carlos Ramiro Zamora-Alemán; Sofía Lizeth Alcaráz-Estrada; Moisés Ortiz-Fernández; Jesús Montoya-Ramírez; Omar Felipe Gaytán-Fuentes; Rebeca Pérez-Cabeza de Vaca; Mónica Escamilla-Tilch; Juan Antonio Pineda-Juárez; Mario Antonio Téllez-González; Paul Mondragón-Terán; Martha Eunice Rodríguez-Arellano; Alejandra Contreras-Ramos; Silvia García; Rolando Efraín Hernández-Muñoz
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.

Authors:  Elisa Waldmann; Thomas P Hüttl; Burkhard Göke; Reinhold Lang; Klaus G Parhofer
Journal:  Lipids Health Dis       Date:  2013-06-01       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.